Overwhelmed by your blood monitoring and prescribing workload? 

Worried about missing a patient’s abnormal blood test result? 

Concerned you will fail to remind a patient who misses a blood test appointment? 

Frustrated by inefficient processes affecting the quality of patient care? 

With the rising prevalence of chronic disease and increasing treatment options, monitoring and prescribing tasks associated to DMARD and Biologics medications are overwhelming NHS staff. With growth predicted to continue at 11% per year, this challenge will only get worse.  

High Risk Medication Monitoring

DAWN Safety Monitoring Software is used in areas including:

Build a case for DAWN in your NHS service

DAWN Safety Monitoring Software is safer for patients and simpler and more efficient for your team.  With DAWN:

Morecambe Bay Hospitals

  • SAVED £50k per annum
  • Halved TIME spent on blood monitoring tasks
  • Enabled a 50-fold REDUCTION in DNA rates!

Gloucester Hospitals

  • HALVED the time needed to complete monitoring tasks
  • While patient numbers TRIPLED
Our Return on Investment calculator will estimate the cost savings of implementing DAWN in your service.
Use our business case template to develop your proposal for implementing DAWN in your service.

DAWN simplifies and improves the monitoring of patients prescribed potentially harmful medication.  It is a robust, yet easy-to-use software which saves clinical staff time, reduces the potential for human error and makes information sharing simple

The time gained allows healthcare staff to focus on other critical tasks, while enhancing the robustness of the process significantly lowers the risk of adverse drug events, ensuring safer and more efficient patient care.

Healthcare service applications of DAWN

DAWN is successfully used within a variety of healthcare settings and departments, including Clinical Haematology, Rheumatology, Dermatology, Neurology, Gastroenterology and Respiratory.

It can be shared across multipe healthcare departments and customised to suit your different clinical guidelines, parameters and individual patient needs.

software screen illustration

11%

per annum growth
in the use of biologics
and biosimilars

3%

absolute harm rate

For every 30 patients treated with biologics, on average one is harmed in some way

80%

of routine monitoring tasks are automated using DAWN

4

times safer

compared to making manual checks on test results